Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 27

Tests names and labsConditionsGenes and analytesMethods

DRPLA - Dentatorubral-Pallidoluysian Atrophy

Center for Genetics at Saint Francis Saint Francis Hospital
United States
11
  • T Targeted variant analysis

ATN1 Gene Sequencing

GENETIX Centro de Investigación en Genética Humana y Reproductiva
Colombia
42
  • T Targeted variant analysis

ATN1. CAG expansion detection by PCR

Instituto de Medicina Genomica
Spain
11
  • T Targeted variant analysis

Dentatorubral-pallidoluysian atrophy

Centogene AG - the Rare Disease Company
Germany
11
  • E Sequence analysis of select exons

Atrophin 1 (ATN1) gene CAG triplet repeat test

Neurogenetics Department Cyprus Institute of Neurology and Genetics
Cyprus
11
  • T Targeted variant analysis

Spinocerebellar ataxia

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
4337
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Dentatorubropallidoluysian atrophy (DRPLA) mutation analysis

Diagnostics Division
India
11
  • T Targeted variant analysis

Dentatorubral-pallidoluysian atrophy

Bioarray
Spain
11
  • C Sequence analysis of the entire coding region

Dentatorubral-pallidoluysian atrophy (DRPLA, CAG repeat expansion on ATN1 gene

CGC Genetics
Portugal
11
  • T Targeted variant analysis

Dentatorubral-pallidoluysian atrophy

Molecular Diagnostics Division Centre for Cellular and Molecular Biology
India
11
  • T Targeted variant analysis

Choreatic Movement Disorders Panel

CeGaT GmbH
Germany
1622
  • C Sequence analysis of the entire coding region

ATN1

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

ATN1

Institute for Human Genetics University Clinic Freiburg
Germany
11
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

DRPLA DNA Test

Athena Diagnostics Inc Quest Diagnostics
United States
11
  • T Targeted variant analysis

Chorea Differential Evaluation

Athena Diagnostics Inc Quest Diagnostics
United States
22
  • T Targeted variant analysis

Autosomal Dominant Ataxia Evaluation

Athena Diagnostics Inc Quest Diagnostics
United States
1414
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Complete Ataxia Evaluation

Athena Diagnostics Inc Quest Diagnostics
United States
2020
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Dentato-rubro-pallido-luysian atrophy

Praxis fuer Humangenetik Wien
Austria
11
  • T Targeted variant analysis

Dentatorubral-pallidoluysian atrophy (DRPLA): ATN1 gene, CAG expansion analysis

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
11
  • C Sequence analysis of the entire coding region

DRPLA

Medizinisch Genetisches Zentrum München MGZ München
Germany
11
  • T Targeted variant analysis

Results: 1 to 20 of 27

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.